Revenue: The sum of all revenue fields included for a company's operating activities.
Harvard Bioscience, Inc. (HBIO) had Revenue of $94.14M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$94.14M |
$-12.40M |
|
$39.37M |
|
$54.77M |
|
$100.35M |
|
$-6.21M |
|
$-5.45M |
|
$-11.66M |
|
$-11.66M |
|
$-12.40M |
|
$-12.40M |
|
$-12.40M |
|
$-12.40M |
|
$-6.21M |
|
$1.27M |
|
43.54M |
|
43.54M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$45.12M |
|
$5.11M |
|
$81.53M |
|
$126.64M |
|
$54.96M |
|
-- |
|
$8.35M |
|
$63.30M |
|
$63.34M |
|
$-4.12M |
|
$63.34M |
|
44.07M |
|
| Cash Flow Statement Financials | |
$1.44M |
|
$-1.34M |
|
$-0.13M |
|
$4.28M |
|
$4.11M |
|
$-0.17M |
|
$4.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
58.18% |
|
-6.60% |
|
-6.60% |
|
1.35% |
|
-12.39% |
|
-13.18% |
|
$-1.20M |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
1.69 |
|
6.33 |
|
57.64 |
|
-19.58% |
|
301.38% |
|
-9.80% |
|
-19.58% |
|
$1.44 |
|
$-0.03 |
|
$0.03 |
|